Information Journal Paper
APA:
Copy. (2017). Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors. INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE (IOVS), 58(-), 1719-1725. SID. https://sid.ir/paper/728088/en
Vancouver:
Copy. Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors. INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE (IOVS)[Internet]. 2017;58(-):1719-1725. Available from: https://sid.ir/paper/728088/en
IEEE:
Copy, “Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors,” INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE (IOVS), vol. 58, no. -, pp. 1719–1725, 2017, [Online]. Available: https://sid.ir/paper/728088/en